Tower Research Capital »

Kymera Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $124k 2.2k 56.60
2025-06-30 $237k 5.4k 43.64
2025-03-31 $70k 2.6k 27.37
2024-12-31 $194k 4.8k 40.23
2024-09-30 $117k 2.5k 47.33
2024-06-30 $392k 13k 29.85
2024-03-31 $28k 704 40.20
2023-09-30 $93k 6.7k 13.91
2023-06-30 $67k 2.9k 22.99
2023-03-31 $52k 1.8k 29.41
2022-12-31 $0 5.4k 0.00
2022-09-30 $404k 19k 21.71
2022-06-30 $229k 12k 19.85
2022-03-31 $135k 3.2k 42.50
2021-12-31 $277k 4.6k 60.00
2021-09-30 $219k 3.7k 59.09
2021-06-30 $83k 1.7k 48.26
2021-03-31 $58k 1.5k 39.08
2020-12-31 $47k 750 62.67
2020-09-30 $31k 970 31.96